Literature DB >> 10610745

Signal-averaged electrocardiogram in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular arrhythmias.

A Nava1, A F Folino, B Bauce, P Turrini, G F Buja, L Daliento, G Thiene.   

Abstract

OBJECTIVE: The aim of the study was to assess the prevalence, sensitivity, specificity and predictive value of the signal-averaged ECG in patients with arrhythmogenic right ventricular cardiomyopathy and different forms of ventricular arrhythmias.
METHODS: The signal averaged ECG in 138 patients and 146 healthy subjects (control group), using a three bandpass filter system (25-250, 40-250, 80-250 Hz), was considered abnormal when at least two parameters were abnormal at each filter setting. Patients were divided into three groups according to the extent of the right ventricular enlargement (mild, moderate, extensive), and into five groups according to the type of ventricular arrhythmia.
RESULTS: The signal averaged ECG was abnormal in 57% of the patients and in 4% of the healthy subjects. The sensitivity was 57%, specificity 95% and positive predictive value 92%. The signal averaged ECG was abnormal in 94.4% of patients with the extensive form of the disease, in 77.7% of patients with the moderate form and in 31.8% of patients with the minor form, demonstrating good correlation with the extent of the disease. According to the type of ventricular arrhythmia, a higher correlation was found between signal averaged ECG abnormality and sustained ventricular tachycardia with superior axis (94.4%, P<0. 02); the correlation for the other arrhythmias varied from 16.6% to 55.8%.
CONCLUSION: There is a closer correlation between the signal averaged ECG and extent of disease than with the presence of ventricular arrhythmias. The signal averaged ECG is not helpful in diagnosing minor forms of the disease, but since it is a non-invasive method, it may be useful in evaluating progression of the disease. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2000        PMID: 10610745     DOI: 10.1053/euhj.1999.1733

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

Review 1.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations.

Authors:  Thomas Herren; Philipp A Gerber; Firat Duru
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

2.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.

Authors:  Frank I Marcus; Wojciech Zareba; Hugh Calkins; Jeffrey A Towbin; Cristina Basso; David A Bluemke; N A Mark Estes; Michael H Picard; Danita Sanborn; Gaetano Thiene; Thomas Wichter; David Cannom; David J Wilber; Melvin Scheinman; Henry Duff; James Daubert; Mario Talajic; Andrew Krahn; Michael Sweeney; Hasan Garan; Scott Sakaguchi; Bruce B Lerman; Charles Kerr; Jack Kron; Jonathan S Steinberg; Duane Sherrill; Kathleen Gear; Mary Brown; Patricia Severski; Slava Polonsky; Scott McNitt
Journal:  Heart Rhythm       Date:  2009-03-11       Impact factor: 6.343

Review 3.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment.

Authors:  E E van der Wall; M Bootsma; H J J Wellens; J J Bax; A de Roos; M J Schalij
Journal:  Neth Heart J       Date:  2003-01       Impact factor: 2.380

4.  Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Ganesh S Kamath; Wojciech Zareba; Jessica Delaney; Jayanthi N Koneru; William McKenna; Kathleen Gear; Slava Polonsky; Duane Sherrill; David Bluemke; Frank Marcus; Jonathan S Steinberg
Journal:  Heart Rhythm       Date:  2010-10-08       Impact factor: 6.343

5.  Correlation between the parameters of signal-averaged ECG and two-dimensional echocardiography in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Yongwhi Park; Yongkeun Cho; Dong-Yeub Lee; Gui-Lyen Jang; Hyunsang Lee; Dong Heon Yang; Hun-Sik Park; Shung-Chull Chae; Jae-Eun Jun; Wee-Hyun Park
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

Review 6.  Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Pietro Turrini; Domenico Corrado; Cristina Basso; Andrea Nava; Gaetano Thiene
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

Review 7.  Utility of SAECG in arrhythmogenic right ventricle dysplasia.

Authors:  Khurram Nasir; Julie Rutberg; Harikrishna Tandri; Ronald Berger; Gordon Tomaselli; Hugh Calkins
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

8.  Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations.

Authors:  Barbara Bauce; Alessandra Rampazzo; Cristina Basso; Elisa Mazzotti; Ilaria Rigato; Alexandros Steriotis; Giorgia Beffagna; Alessandra Lorenzon; Marzia De Bortoli; Kalliopi Pilichou; Martina Perazzolo Marra; Francesco Corbetti; Luciano Daliento; Sabino Iliceto; Domenico Corrado; Gaetano Thiene; Andrea Nava
Journal:  Heart Rhythm       Date:  2011-06-30       Impact factor: 6.343

9.  Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Ardan M Saguner; Sabrina Ganahl; Andrea Kraus; Samuel H Baldinger; Deniz Akdis; Arhan R Saguner; Thomas Wolber; Laurent M Haegeli; Jan Steffel; Nazmi Krasniqi; Thomas F Lüscher; Felix C Tanner; Corinna Brunckhorst; Firat Duru
Journal:  BMC Cardiovasc Disord       Date:  2015-01-19       Impact factor: 2.298

Review 10.  Signal-averaged electrocardiography: Past, present, and future.

Authors:  Konstantinos A Gatzoulis; Petros Arsenos; Konstantinos Trachanas; Polychronis Dilaveris; Christos Antoniou; Dimitris Tsiachris; Skevos Sideris; Theofilos M Kolettis; Dimitrios Tousoulis
Journal:  J Arrhythm       Date:  2018-05-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.